ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006